Cannabis Reform Could be a Top Priority in 2021

Cannabis-based products are popping up everywhere these days.

Neiman Marcus, Sephora, Vitamin Shoppe, Kroger, Barney’s DSW, Sephora, CVS, American Eagle, Walgreen’s, Wegman’s are just a few. Couple that with changing consumer attitudes, and the CB boom only gets stronger. “Americans are more likely now than at any point in the past five decades to support the legalization of MJ in the U.S. The 68% of U.S. adults who currently back the measure is not statistically different from last year's 66%; however, it is nominally Gallup's highest reading, exceeding the 64% to 66% range seen from 2017 to 2019.”

By 2024, the market is expected to grow to nearly $50 billion.

In addition, Senate Democrats say cannabis reform will be higher priority.

“We are committed to working together to put forward and advance comprehensive cannabis reform legislation that will not only turn the page on this sad chapter in American history, but also undo the devastating consequences of these discriminatory policies,” said Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ), as quoted by Marijuana Moment. “The Senate will make consideration of these reforms a priority.”

That could be substantial news for some of the top cannabis stocks, such as Canopy Growth Corporation (NASDAQ:CGC)(TSX:WEED), Tilray Inc. (NASDAQ:TLRY), and HEXO Corporation (NYSE:HEXO)(TSX:HEXO), and OrganiGram Holdings Inc. (NASDAQ:OGI)(TSX:OGI).

It’s also good news for companies like Arev NanoTec Brands Inc. (CSE: AREV)(OTC: AREVF).

AREV produces functional ingredients through its proprietary extraction systems and methods.

It’s applying nanotech methods to create premium ingredients for products that have an increased bioavailability. Then, it sells product to targeted natural health, medical, functional food, nutraceutical, sport nutrition markets.

Most recently, Arev NanoTec Brands announced that it has retained the services of Dr. Uma V. A. Dhanabalan, MD MPH FAAFP MRO CMS to join the Advisory Board for AREV Nanotec Brands Inc, consult on AREV product development sciences, act as a product ambassador on the function of the AREV formulations in events and consulting through clinics.

Dr. Dhanabalan is a highly respected physician, graduated from UMDNJ, Newark, New Jersey and trained in Family Medicine at MUSC in Charleston, South Carolina, and earned her Master’s in Public Health and trained in Occupational & Environmental Medicine, and Fellowship in Heavy Metals at Harvard School of Public Health in Boston, Massachusetts. She is a Fellow of the American Academy of Family Physicians, a Diplomat Certified in Cannabinoid Medicine and a Medical Review Officer.

Dr. Dhanabalan is the Founder/CEO of Global Health & Hygiene Solutions, LLC whose mission is to promote wellness and prevent illness locally and globally. She runs an Independent practice at Uplifting Health & Wellness in Cambridge, MA where she provides tools to all ages from various backgrounds. Her goal is to “Educate, Embrace & Empower” her patients and the public with safe and effective alternative treatment options, including cannabis.

Dr. Dhanabalan believes that “Cannabis is not for everyone, yet it should be the first line option, not the last resort.”™ “Cannabis is an exit drug from pharmaceuticals, narcotics, alcohol and nicotine; it is an entrance to a better quality of life.”™

CEO, Mike Withrow commented, “We welcome Dr. Dhanabalan to the AREV Nanotec Scientific Advisory Board. Dr. Uma as many know her as is an early leader in cannabinoid medicine and has helped thousands of people overcome illness. We are fortunate to have her to advise us on the interworking of our products within the human body. This will lead us to delivering efficacious products people can trust to maintain good health.”

Dr. Dhanabalan commented, “I am excited to be part of the AREV NanoTec team. I am here to use my experience and work together with AREV’s technology to create safe, effective products to improve health and wellness around the globe.” The Company has issued 50,000 stock options to Directors, Officers and Consultants of the Company at a price of $0.275 for a period of 5 years from the issuance dated. These options will vest immediately.

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for Arev NanoTec Brands Inc. by a third party. We own ZERO shares of Arev NanoTec Brands Inc. Please click here for full disclaimer.

Contact Information:
[email protected]